{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:27:46Z","timestamp":1794644866821,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2056 - project ID 390715994"],"award-info":[{"award-number":["EXC 2056 - project ID 390715994"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2056 - project ID 390715994"],"award-info":[{"award-number":["EXC 2056 - project ID 390715994"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2056 - project ID 390715994"],"award-info":[{"award-number":["EXC 2056 - project ID 390715994"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joachim-Herz-Stiftung, Hamburg","award":["Infecto-Physics"],"award-info":[{"award-number":["Infecto-Physics"]}]},{"name":"Joachim-Herz-Stiftung, Hamburg","award":["Infecto-Physics"],"award-info":[{"award-number":["Infecto-Physics"]}]},{"name":"Joachim-Herz-Stiftung, Hamburg","award":["Infecto-Physics"],"award-info":[{"award-number":["Infecto-Physics"]}]},{"name":"Joachim-Herz-Stiftung, Hamburg","award":["Infecto-Physics"],"award-info":[{"award-number":["Infecto-Physics"]}]},{"name":"Joachim-Herz-Stiftung, Hamburg","award":["Infecto-Physics"],"award-info":[{"award-number":["Infecto-Physics"]}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["05K19GU4"],"award-info":[{"award-number":["05K19GU4"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005711","name":"Universit\u00e4t Hamburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\u03b2-lactamases are a major cause of rapidly emerging and spreading antibiotic resistance. Currently \u03b2-lactamase inhibitors (BLIs) in clinical use act only on Ambler Class A, C and some class D lactamases. The urgent need to identify new BLIs recently lead to FDA approval of boron-based compounds BLIs, e.g. Vaborbactam. The boron-based proteasome inhibitors Bortezomib and Ixazomib are used in cancer therapy as multiple myeloma drugs but they also bind to Ser-\/Thr- proteases. In this study we show the crystal structures of the \u03b2-lactamase CTX-M-14 with covalently bound Bortezomib and Ixazomib at high resolutions of 1.3 and 1.1\u00a0\u00c5, respectively. Ixazomib is well defined in electron density whereas Bortezomib show some disorder which corresponds to weaker inhibition efficiency observed for Ixazomib. Both inhibitors mimic the deacylation transition state of \u03b2-lactam hydrolysis, because they replace the deacylating water molecule. We further investigate differences in binding of Bortezomib\/Ixazomib to CTX-M-14 and its target proteases as well as known \u03b2-lactamase drugs. Our findings can help to use Bortezomib\/Ixazomib as lead compounds for development of new BLIs.<\/jats:p>","DOI":"10.1038\/s41598-022-09392-6","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T10:21:23Z","timestamp":1648808483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Structural basis to repurpose boron-based proteasome inhibitors Bortezomib and Ixazomib as \u03b2-lactamase inhibitors"],"prefix":"10.1038","volume":"12","author":[{"given":"Markus","family":"Perbandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Prester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Aepfelbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Hinrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Betzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"9392_CR1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025247","author":"K Bush","year":"2016","unstructured":"Bush, K. & Bradford, P. A. Beta-Lactams and beta-Lactamase Inhibitors: An Overview. Cold Spring Harb. Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a025247 (2016).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"9392_CR2","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1073\/pnas.76.6.2730","volume":"76","author":"RR Yocum","year":"1979","unstructured":"Yocum, R. R., Waxman, D. J., Rasmussen, J. R. & Strominger, J. L. Mechanism of penicillin action: penicillin and substrate bind covalently to the same active site serine in two bacterial D-alanine carboxypeptidases. Proc. Natl. Acad. Sci. U S A 76, 2730\u20132734. https:\/\/doi.org\/10.1073\/pnas.76.6.2730 (1979).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"9392_CR3","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1073\/pnas.54.4.1133","volume":"54","author":"DJ Tipper","year":"1965","unstructured":"Tipper, D. J. & Strominger, J. L. Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine. Proc. Natl. Acad. Sci. U S A 54, 1133\u20131141. https:\/\/doi.org\/10.1073\/pnas.54.4.1133 (1965).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"9392_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41579-019-0159-8","volume":"17","author":"K Bush","year":"2019","unstructured":"Bush, K. & Bradford, P. A. Interplay between beta-lactamases and new beta-lactamase inhibitors. Nat. Rev. Microbiol. 17, 295\u2013306. https:\/\/doi.org\/10.1038\/s41579-019-0159-8 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"9392_CR5","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","author":"JM Munita","year":"2016","unstructured":"Munita, J. M. & Arias, C. A. Mechanisms of Antibiotic Resistance. Microbiol. Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.VMBF-0016-2015 (2016).","journal-title":"Microbiol. Spectr."},{"key":"9392_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/2049936115621709","volume":"3","author":"G Meletis","year":"2016","unstructured":"Meletis, G. Carbapenem resistance: overview of the problem and future perspectives. Ther. Adv. Infect. Dis. 3, 15\u201321. https:\/\/doi.org\/10.1177\/2049936115621709 (2016).","journal-title":"Ther. Adv. Infect. Dis."},{"key":"9392_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1098\/rstb.1980.0049","volume":"289","author":"RP Ambler","year":"1980","unstructured":"Ambler, R. P. The structure of beta-lactamases. Philos. Trans. R Soc. Lond. B Biol. Sci. 289, 321\u2013331. https:\/\/doi.org\/10.1098\/rstb.1980.0049 (1980).","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"key":"9392_CR8","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/jac\/dki130","volume":"55","author":"BG Hall","year":"2005","unstructured":"Hall, B. G. & Barlow, M. Revised Ambler classification of {beta}-lactamases. J. Antimicrob Chemother 55, 1050\u20131051. https:\/\/doi.org\/10.1093\/jac\/dki130 (2005).","journal-title":"J. Antimicrob Chemother"},{"key":"9392_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1749-6632.2012.06796.x","volume":"1277","author":"T Palzkill","year":"2013","unstructured":"Palzkill, T. Metallo-beta-lactamase structure and function. Ann. N Y Acad. Sci. 1277, 91\u2013104. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06796.x (2013).","journal-title":"Ann. N Y Acad. Sci."},{"key":"9392_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fmicb.2012.00110","volume":"3","author":"R Canton","year":"2012","unstructured":"Canton, R., Gonzalez-Alba, J. M. & Galan, J. C. CTX-M enzymes: origin and diffusion. Front. Microbiol. 3, 110. https:\/\/doi.org\/10.3389\/fmicb.2012.00110 (2012).","journal-title":"Front. Microbiol."},{"key":"9392_CR11","doi-asserted-by":"publisher","first-page":"19044","DOI":"10.2807\/ese.13.47.19044-en","volume":"13","author":"TM Coque","year":"2008","unstructured":"Coque, T. M., Baquero, F. & Canton, R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Eur. Surveill. 13, 19044 (2008).","journal-title":"Eur. Surveill."},{"key":"9392_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JD Pitout","year":"2008","unstructured":"Pitout, J. D. & Laupland, K. B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8, 159\u2013166. https:\/\/doi.org\/10.1016\/S1473-3099(08)70041-0 (2008).","journal-title":"Lancet Infect. Dis."},{"key":"9392_CR13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.mib.2006.08.011","volume":"9","author":"R Canton","year":"2006","unstructured":"Canton, R. & Coque, T. M. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9, 466\u2013475. https:\/\/doi.org\/10.1016\/j.mib.2006.08.011 (2006).","journal-title":"Curr. Opin. Microbiol."},{"issue":"Suppl 1","key":"9392_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1469-0691.2007.01850.x","volume":"14","author":"R Canton","year":"2008","unstructured":"Canton, R. et al. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin. Microbiol. Infect 14(Suppl 1), 144\u2013153. https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01850.x (2008).","journal-title":"Clin. Microbiol. Infect"},{"key":"9392_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1292\/jvms.11-0372","volume":"74","author":"M Hiroi","year":"2012","unstructured":"Hiroi, M. et al. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in food-producing animals. J. Vet. Med. Sci. 74, 189\u2013195. https:\/\/doi.org\/10.1292\/jvms.11-0372 (2012).","journal-title":"J. Vet. Med. Sci."},{"key":"9392_CR16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/AAC.01009-09","volume":"54","author":"K Bush","year":"2010","unstructured":"Bush, K. & Jacoby, G. A. Updated functional classification of beta-lactamases. Antimicrob. Agents Chemother. 54, 969\u2013976. https:\/\/doi.org\/10.1128\/AAC.01009-09 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9392_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fmicb.2013.00392","volume":"4","author":"RR Watkins","year":"2013","unstructured":"Watkins, R. R., Papp-Wallace, K. M., Drawz, S. M. & Bonomo, R. A. Novel beta-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance. Front. Microbiol. 4, 392. https:\/\/doi.org\/10.3389\/fmicb.2013.00392 (2013).","journal-title":"Front. Microbiol."},{"key":"9392_CR18","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/QCO.0000000000000600","volume":"32","author":"A Vena","year":"2019","unstructured":"Vena, A., Castaldo, N. & Bassetti, M. The role of new beta-lactamase inhibitors in gram-negative infections. Curr. Opin. Infect. Dis. 32, 638\u2013646. https:\/\/doi.org\/10.1097\/QCO.0000000000000600 (2019).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"9392_CR19","doi-asserted-by":"publisher","first-page":"11663","DOI":"10.1073\/pnas.1205073109","volume":"109","author":"DE Ehmann","year":"2012","unstructured":"Ehmann, D. E. et al. Avibactam is a covalent, reversible, non-beta-lactam beta-lactamase inhibitor. Proc. Natl. Acad. Sci. U S A 109, 11663\u201311668. https:\/\/doi.org\/10.1073\/pnas.1205073109 (2012).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"9392_CR20","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1093\/jac\/dkt178","volume":"68","author":"DM Livermore","year":"2013","unstructured":"Livermore, D. M., Warner, M. & Mushtaq, S. Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa. J. Antimicrob. Chemother. 68, 2286\u20132290. https:\/\/doi.org\/10.1093\/jac\/dkt178 (2013).","journal-title":"J. Antimicrob. Chemother."},{"key":"9392_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00564-19","author":"CL Tooke","year":"2019","unstructured":"Tooke, C. L. et al. Molecular basis of class A beta-lactamase inhibition by relebactam. Antimicrob. Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00564-19 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9392_CR22","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.2174\/0929867321666140601200803","volume":"21","author":"H Fu","year":"2014","unstructured":"Fu, H. et al. Boronic acid-based enzyme inhibitors: a review of recent progress. Curr. Med. Chem. 21, 3271\u20133280. https:\/\/doi.org\/10.2174\/0929867321666140601200803 (2014).","journal-title":"Curr. Med. Chem."},{"key":"9392_CR23","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1021\/ja042850a","volume":"127","author":"Y Chen","year":"2005","unstructured":"Chen, Y., Shoichet, B. & Bonnet, R. Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases. J. Am. Chem. Soc. 127, 5423\u20135434. https:\/\/doi.org\/10.1021\/ja042850a (2005).","journal-title":"J. Am. Chem. Soc."},{"key":"9392_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1021\/acsinfecdis.7b00153","volume":"4","author":"E Caselli","year":"2018","unstructured":"Caselli, E. et al. Inhibition of acinetobacter-derived cephalosporinase: exploring the carboxylate recognition site using novel beta-lactamase inhibitors. ACS Infect. Dis. 4, 337\u2013348. https:\/\/doi.org\/10.1021\/acsinfecdis.7b00153 (2018).","journal-title":"ACS Infect. Dis."},{"key":"9392_CR25","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1021\/acs.jmedchem.5b00127","volume":"58","author":"SJ Hecker","year":"2015","unstructured":"Hecker, S. J. et al. Discovery of a cyclic boronic acid beta-lactamase inhibitor (RPX7009) with utility vs class A serine carbapenemases. J. Med. Chem. 58, 3682\u20133692. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00127 (2015).","journal-title":"J. Med. Chem."},{"key":"9392_CR26","doi-asserted-by":"publisher","first-page":"D464","DOI":"10.1093\/nar\/gky1004","volume":"47","author":"SK Burley","year":"2019","unstructured":"Burley, S. K. et al. RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy. Nucleic Acids Res. 47, D464\u2013D474. https:\/\/doi.org\/10.1093\/nar\/gky1004 (2019).","journal-title":"Nucleic Acids Res."},{"key":"9392_CR27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nchem.2814","volume":"9","author":"DB Diaz","year":"2017","unstructured":"Diaz, D. B. & Yudin, A. K. The versatility of boron in biological target engagement. Nat. Chem. 9, 731\u2013742. https:\/\/doi.org\/10.1038\/nchem.2814 (2017).","journal-title":"Nat. Chem."},{"key":"9392_CR28","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1158\/0008-5472.CAN-09-2766","volume":"70","author":"E Kupperman","year":"2010","unstructured":"Kupperman, E. et al. Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer. Cancer Res. 70, 1970\u20131980. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-2766 (2010).","journal-title":"Cancer Res."},{"key":"9392_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40265-016-0548-5","volume":"76","author":"M Shirley","year":"2016","unstructured":"Shirley, M. Ixazomib: first global approval. Drugs 76, 405\u2013411. https:\/\/doi.org\/10.1007\/s40265-016-0548-5 (2016).","journal-title":"Drugs"},{"key":"9392_CR30","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1158\/1078-0432.CCR-06-0170","volume":"12","author":"RC Kane","year":"2006","unstructured":"Kane, R. C., Farrell, A. T., Sridhara, R. & Pazdur, R. United States Food and Drug Administration approval summary: bortezomib for the treatment of progressive multiple myeloma after one prior therapy. Clin. Cancer Res. 12, 2955\u20132960. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0170 (2006).","journal-title":"Clin. Cancer Res."},{"key":"9392_CR31","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1126\/science.aaf8993","volume":"353","author":"J Schrader","year":"2016","unstructured":"Schrader, J. et al. The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design. Science 353, 594\u2013598. https:\/\/doi.org\/10.1126\/science.aaf8993 (2016).","journal-title":"Science"},{"key":"9392_CR32","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1107\/S0907444913008214","volume":"69","author":"JH Liao","year":"2013","unstructured":"Liao, J. H. et al. Structures of an ATP-independent Lon-like protease and its complexes with covalent inhibitors. Acta Crystallogr. D Biol. Crystallogr. 69, 1395\u20131402. https:\/\/doi.org\/10.1107\/S0907444913008214 (2013).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"9392_CR33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.str.2016.03.003","volume":"24","author":"SC Su","year":"2016","unstructured":"Su, S. C. et al. Structural basis for the magnesium-dependent activation and hexamerization of the Lon AAA+ protease. Structure 24, 676\u2013686. https:\/\/doi.org\/10.1016\/j.str.2016.03.003 (2016).","journal-title":"Structure"},{"key":"9392_CR34","doi-asserted-by":"publisher","first-page":"eaaw3818","DOI":"10.1126\/sciadv.aaw3818","volume":"5","author":"J Felix","year":"2019","unstructured":"Felix, J. et al. Mechanism of the allosteric activation of the ClpP protease machinery by substrates and active-site inhibitors. Sci. Adv. 5, eaaw3818. https:\/\/doi.org\/10.1126\/sciadv.aaw3818 (2019).","journal-title":"Sci. Adv."},{"key":"9392_CR35","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01518","author":"B Liu","year":"2019","unstructured":"Liu, B. et al. Discovery of taniborbactam (VNRX-5133): a broad-spectrum serine- and metallo-beta-lactamase inhibitor for carbapenem-resistant bacterial infections. J. Med. Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01518 (2019).","journal-title":"J. Med. Chem."},{"key":"9392_CR36","doi-asserted-by":"publisher","first-page":"8544","DOI":"10.1021\/acs.jmedchem.9b00911","volume":"62","author":"A Krajnc","year":"2019","unstructured":"Krajnc, A. et al. Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-beta-Lactamases. J. Med. Chem. 62, 8544\u20138556. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00911 (2019).","journal-title":"J. Med. Chem."},{"key":"9392_CR37","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0040-4020(01)82006-8","volume":"46","author":"RA Firestone","year":"1990","unstructured":"Firestone, R. A., Barker, P. L., Pisano, J. M., Ashe, B. M. & Dahlgren, M. E. Monocyclic beta-Lactam Inhibitors of Human-Leukocyte Elastase. Tetrahedron 46, 2255\u20132262 (1990).","journal-title":"Tetrahedron"},{"key":"9392_CR38","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nsb0896-688","volume":"3","author":"NC Strynadka","year":"1996","unstructured":"Strynadka, N. C., Martin, R., Jensen, S. E., Gold, M. & Jones, J. B. Structure-based design of a potent transition state analogue for TEM-1 beta-lactamase. Nat. Struct. Biol. 3, 688\u2013695. https:\/\/doi.org\/10.1038\/nsb0896-688 (1996).","journal-title":"Nat. Struct. Biol."},{"key":"9392_CR39","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1128\/AAC.06099-11","volume":"56","author":"W Ke","year":"2012","unstructured":"Ke, W. et al. Crystal structures of KPC-2 beta-lactamase in complex with 3-nitrophenyl boronic acid and the penam sulfone PSR-3-226. Antimicrob. Agents Chemother. 56, 2713\u20132718. https:\/\/doi.org\/10.1128\/AAC.06099-11 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9392_CR40","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/359700a0","volume":"359","author":"NC Strynadka","year":"1992","unstructured":"Strynadka, N. C. et al. Molecular structure of the acyl-enzyme intermediate in beta-lactam hydrolysis at 1.7 A resolution. Nature 359, 700\u2013705. https:\/\/doi.org\/10.1038\/359700a0 (1992).","journal-title":"Nature"},{"key":"9392_CR41","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1021\/acscatal.7b04114","volume":"8","author":"PS Langan","year":"2018","unstructured":"Langan, P. S. et al. Substrate binding induces conformational changes in a class a beta-lactamase that prime it for catalysis. Acs Catal. 8, 2428\u20132437. https:\/\/doi.org\/10.1021\/acscatal.7b04114 (2018).","journal-title":"Acs Catal."},{"key":"9392_CR42","doi-asserted-by":"publisher","first-page":"8086","DOI":"10.1021\/jacs.5b00749","volume":"137","author":"DA Nichols","year":"2015","unstructured":"Nichols, D. A. et al. Ligand-induced proton transfer and low-barrier hydrogen bond revealed by X-ray crystallography. J. Am. Chem. Soc. 137, 8086\u20138095. https:\/\/doi.org\/10.1021\/jacs.5b00749 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"9392_CR43","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1074\/jbc.RA119.012489","volume":"295","author":"CA Brown","year":"2020","unstructured":"Brown, C. A. et al. Antagonism between substitutions in beta-lactamase explains a path not taken in the evolution of bacterial drug resistance. J. Biol. Chem. 295, 7376\u20137390. https:\/\/doi.org\/10.1074\/jbc.RA119.012489 (2020).","journal-title":"J. Biol. Chem."},{"key":"9392_CR44","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/jac\/dkh358","volume":"54","author":"A Bonnefoy","year":"2004","unstructured":"Bonnefoy, A. et al. In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor. J. Antimicrob. Chemother 54, 410\u2013417. https:\/\/doi.org\/10.1093\/jac\/dkh358 (2004).","journal-title":"J. Antimicrob. Chemother"},{"key":"9392_CR45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1107\/S2059798319016334","volume":"76","author":"PS Langan","year":"2020","unstructured":"Langan, P. S., Sullivan, B., Weiss, K. L. & Coates, L. Probing the role of the conserved residue Glu166 in a class A beta-lactamase using neutron and X-ray protein crystallography. Acta Crystallogr. D Struct. Biol. 76, 118\u2013123. https:\/\/doi.org\/10.1107\/S2059798319016334 (2020).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"9392_CR46","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2018.0438","volume":"319","author":"KS Kaye","year":"2018","unstructured":"Kaye, K. S. et al. Effect of meropenem-vaborbactam vs piperacillin-tazobactam on clinical cure or improvement and microbial eradication in complicated urinary tract infection: the TANGO I randomized clinical trial. JAMA 319, 788\u2013799. https:\/\/doi.org\/10.1001\/jama.2018.0438 (2018).","journal-title":"JAMA"},{"key":"9392_CR47","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","volume":"431","author":"CL Tooke","year":"2019","unstructured":"Tooke, C. L. et al. beta-Lactamases and beta-Lactamase Inhibitors in the 21st Century. J. Mol. Biol. 431, 3472\u20133500. https:\/\/doi.org\/10.1016\/j.jmb.2019.04.002 (2019).","journal-title":"J. Mol. Biol."},{"key":"9392_CR48","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1038\/s41467-018-06156-7","volume":"9","author":"MO Wiedorn","year":"2018","unstructured":"Wiedorn, M. O. et al. Megahertz serial crystallography. Nat. Commun. 9, 4025. https:\/\/doi.org\/10.1038\/s41467-018-06156-7 (2018).","journal-title":"Nat. Commun."},{"key":"9392_CR49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12915-018-0524-5","volume":"16","author":"JL Olmos Jr","year":"2018","unstructured":"Olmos, J. L. Jr. et al. Enzyme intermediates captured \u201con the fly\u201d by mix-and-inject serial crystallography. BMC Biol. 16, 59. https:\/\/doi.org\/10.1186\/s12915-018-0524-5 (2018).","journal-title":"BMC Biol."},{"key":"9392_CR50","doi-asserted-by":"publisher","first-page":"S401","DOI":"10.1107\/S0108767313096505","volume":"69","author":"A Burkhardt","year":"2013","unstructured":"Burkhardt, A. et al. The crystallography endstation at beamline P11 at PETRA III. Acta Crystallogr. a-Found. Adv. 69, S401\u2013S401. https:\/\/doi.org\/10.1107\/S0108767313096505 (2013).","journal-title":"Acta Crystallogr. a-Found. Adv."},{"key":"9392_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125\u2013132. https:\/\/doi.org\/10.1107\/S0907444909047337 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"9392_CR52","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861\u2013877. https:\/\/doi.org\/10.1107\/S2059798319011471 (2019).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"9392_CR53","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D Biol. Crystallogr. 68, 352\u2013367. https:\/\/doi.org\/10.1107\/S0907444912001308 (2012).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"9392_CR54","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D-Biol. Crystallogr. 66, 486\u2013501. https:\/\/doi.org\/10.1107\/S0907444910007493 (2010).","journal-title":"Acta Crystallogr. Sect. D-Biol. Crystallogr."},{"key":"9392_CR55","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1107\/S2059798316018210","volume":"73","author":"D Liebschner","year":"2017","unstructured":"Liebschner, D. et al. Polder maps: improving OMIT maps by excluding bulk solvent. Acta Crystallogr. D Struct. Biol. 73, 148\u2013157. https:\/\/doi.org\/10.1107\/S2059798316018210 (2017).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"9392_CR56","doi-asserted-by":"publisher","first-page":"S311","DOI":"10.1107\/S010876731009286x","volume":"66","author":"A Urzhumtsev","year":"2010","unstructured":"Urzhumtsev, A., Afonine, P. V., Urzhumtseva, L. & Adams, P. D. POLYGON and other tools: model validation at a glance. Acta Crystallogr. a-Found. Adv. 66, S311\u2013S312. https:\/\/doi.org\/10.1107\/S010876731009286x (2010).","journal-title":"Acta Crystallogr. a-Found. Adv."},{"key":"9392_CR57","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams, C. J. et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 27, 293\u2013315. https:\/\/doi.org\/10.1002\/pro.3330 (2018).","journal-title":"Protein Sci."},{"key":"9392_CR58","unstructured":"Schr\u00f6dinger, L., & DeLano, W. (PyMOL. Retrieved from http:\/\/www.pymol.org\/pymol. (2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09392-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09392-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:00:45Z","timestamp":1669338045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09392-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9392"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09392-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"assertion":[{"value":"13 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5510"}}